Trial Details
RECRUITINGBasic Information
| Clinical ID | c2531 |
|---|---|
| Identifier | NCT03339128 |
| Trial Title | Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: Eluxadoline|DRUG: Placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Hot Springs |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2017-11-15 |
|---|---|
| Primary Completion Date | 2026-12 |
| Completion Date | 2026-12 |